Skip to main navigation Skip to search Skip to main content

Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma

  • Pilar de la Puente
  • , Micah J. Luderer
  • , Cinzia Federico
  • , Abbey Jin
  • , Rebecca C. Gilson
  • , Christopher Egbulefu
  • , Kinan Alhallak
  • , Shruti Shah
  • , Barbara Muz
  • , Jennifer Sun
  • , Justin King
  • , Daniel Kohnen
  • , Noha Nabil Salama
  • , Samuel Achilefu
  • , Ravi Vij
  • , Abdel Kareem Azab
  • Department of Radiation Oncology
  • Washington University School of Medicine in St. Louis
  • St. Louis College of Pharmacy
  • Mallinckrodt Institute of Radiology
  • Section of Stem Cell Transplant and Leukemia
  • Division of Medical Oncology
  • Cairo University Faculty of Pharmacy

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)158-176
Number of pages19
JournalJournal of Controlled Release
Volume270
DOIs
StatePublished - Jan 28 2018

ASJC Scopus Subject Areas

  • Pharmaceutical Science

Keywords

  • Bortezomib
  • CD38
  • Endocytosis
  • Nanoparticles, multiple myeloma

Cite this